Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
109520115 | 10952011 | 5 | F | 20120118 | 20160912 | 20150325 | 20160915 | EXP | BR-ROCHE-1400690 | ROCHE | 46.21 | YR | F | Y | 57.00000 | KG | 20160915 | OT | BR | BR |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
109520115 | 10952011 | 1 | PS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | DATE OF LATEST RITUXIMAB INFUSION: 16/FEB/2016 | U | 103705 | SOLUTION FOR INFUSION | ||||||||
109520115 | 10952011 | 2 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 103705 | SOLUTION FOR INFUSION | |||||||||
109520115 | 10952011 | 3 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 103705 | SOLUTION FOR INFUSION | |||||||||
109520115 | 10952011 | 4 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 103705 | SOLUTION FOR INFUSION | |||||||||
109520115 | 10952011 | 5 | SS | MABTHERA | RITUXIMAB | 1 | Intravenous (not otherwise specified) | U | 103705 | SOLUTION FOR INFUSION | |||||||||
109520115 | 10952011 | 6 | SS | CIPRO | CIPROFLOXACIN HYDROCHLORIDE | 1 | Unknown | U | 0 | ||||||||||
109520115 | 10952011 | 7 | SS | CORTISONE | CORTISONEHYDROCORTISONE | 1 | Unknown | U | 0 | ||||||||||
109520115 | 10952011 | 8 | SS | ARADOIS | LOSARTAN POTASSIUM | 1 | Unknown | U | 0 | ||||||||||
109520115 | 10952011 | 9 | SS | CONCOR | BISOPROLOL FUMARATE | 1 | Unknown | U | 0 | ||||||||||
109520115 | 10952011 | 10 | C | CLOPIDOGREL BISULFATE. | CLOPIDOGREL BISULFATE | 1 | Unknown | 0 | 175 | MG | |||||||||
109520115 | 10952011 | 11 | C | PRELONE | PREDNISOLONE | 1 | Oral | ALTERNATE DAYS | 0 | 3 | MG | ||||||||
109520115 | 10952011 | 12 | C | SYNTHROID | LEVOTHYROXINE SODIUM | 1 | Unknown | 0 | 75 | MG | |||||||||
109520115 | 10952011 | 13 | C | PARIET | RABEPRAZOLE SODIUM | 1 | Unknown | 0 | 20 | MG | |||||||||
109520115 | 10952011 | 14 | C | VYTORIN | EZETIMIBESIMVASTATIN | 1 | Unknown | 10/40 | 0 | ||||||||||
109520115 | 10952011 | 15 | C | MONTELAIR | MONTELUKAST SODIUM | 1 | Unknown | 0 | 10 | MG | |||||||||
109520115 | 10952011 | 16 | C | ASPIRIN. | ASPIRIN | 1 | Unknown | 0 | 100 | MG | |||||||||
109520115 | 10952011 | 17 | C | TRAYENTA DUO | LINAGLIPTINMETFORMIN HYDROCHLORIDE | 1 | Unknown | 0 | 25 | MG | |||||||||
109520115 | 10952011 | 18 | C | DEPURA | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
109520115 | 10952011 | 19 | C | MACRODANTIN | NITROFURANTOIN | 1 | 0 | ||||||||||||
109520115 | 10952011 | 20 | C | AZATHIOPRINE. | AZATHIOPRINE | 1 | Unknown | 0 | 150 | MG | |||||||||
109520115 | 10952011 | 21 | C | RIVOTRIL | CLONAZEPAM | 1 | Unknown | 0 | 2 | MG | |||||||||
109520115 | 10952011 | 22 | C | RIVOTRIL | CLONAZEPAM | 1 | Unknown | 0 | 1 | MG | |||||||||
109520115 | 10952011 | 23 | C | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | 0 | ||||||||||||
109520115 | 10952011 | 24 | C | VASTAREL | TRIMETAZIDINE DIHYDROCHLORIDE | 1 | 0 | ||||||||||||
109520115 | 10952011 | 25 | C | DIPYRONE | DIPYRONE | 1 | 0 | ||||||||||||
109520115 | 10952011 | 26 | C | AZATHIOPRINE. | AZATHIOPRINE | 1 | 0 | ||||||||||||
109520115 | 10952011 | 27 | C | PRELONE | PREDNISOLONE | 1 | 0 | ||||||||||||
109520115 | 10952011 | 28 | C | CLOPINE | CLOZAPINE | 1 | Unknown | 0 | 75 | MG | |||||||||
109520115 | 10952011 | 29 | C | ATORVASTATIN | ATORVASTATIN | 1 | Unknown | 0 | 20 | MG | |||||||||
109520115 | 10952011 | 30 | C | EZETROL | EZETIMIBE | 1 | Unknown | 0 | 10 | MG | |||||||||
109520115 | 10952011 | 31 | C | EZETROL | EZETIMIBE | 1 | 0 | ||||||||||||
109520115 | 10952011 | 32 | C | SIGMATRIOL | CALCITRIOL | 1 | Unknown | 0 | .25 | MG | |||||||||
109520115 | 10952011 | 33 | C | VITAMIN D3 | CHOLECALCIFEROL | 1 | 0 | ||||||||||||
109520115 | 10952011 | 34 | C | TRAMAL | TRAMADOL | 1 | Unknown | 0 | 50 | MG | |||||||||
109520115 | 10952011 | 35 | C | ACETYLSALICYLIC ACID | ASPIRIN | 1 | Unknown | 0 | 100 | MG |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
109520115 | 10952011 | 1 | Rheumatoid arthritis |
109520115 | 10952011 | 6 | Product used for unknown indication |
109520115 | 10952011 | 7 | Product used for unknown indication |
109520115 | 10952011 | 8 | Product used for unknown indication |
109520115 | 10952011 | 9 | Product used for unknown indication |
109520115 | 10952011 | 12 | Thyroid disorder |
109520115 | 10952011 | 15 | Lung disorder |
109520115 | 10952011 | 21 | Pain |
109520115 | 10952011 | 25 | Pain |
109520115 | 10952011 | 30 | Blood cholesterol abnormal |
109520115 | 10952011 | 31 | Blood triglycerides abnormal |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
109520115 | 10952011 | OT |
109520115 | 10952011 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
109520115 | 10952011 | Anaemia | |
109520115 | 10952011 | Arterial occlusive disease | |
109520115 | 10952011 | Arthralgia | |
109520115 | 10952011 | Asthenia | |
109520115 | 10952011 | Blood cholesterol increased | |
109520115 | 10952011 | Blood glucose increased | |
109520115 | 10952011 | Blood triglycerides increased | |
109520115 | 10952011 | Cardiac failure congestive | |
109520115 | 10952011 | Conjunctivitis | |
109520115 | 10952011 | Depression | |
109520115 | 10952011 | Disturbance in attention | |
109520115 | 10952011 | Dizziness | |
109520115 | 10952011 | Drug hypersensitivity | |
109520115 | 10952011 | Dysbacteriosis | |
109520115 | 10952011 | Dysstasia | |
109520115 | 10952011 | Fall | |
109520115 | 10952011 | Finger deformity | |
109520115 | 10952011 | Fluid retention | |
109520115 | 10952011 | Gait disturbance | |
109520115 | 10952011 | Gastric haemorrhage | |
109520115 | 10952011 | Glaucoma | |
109520115 | 10952011 | Glucose tolerance impaired | |
109520115 | 10952011 | H1N1 influenza | |
109520115 | 10952011 | Haemorrhage | |
109520115 | 10952011 | Hepatitis | |
109520115 | 10952011 | Hypersensitivity | |
109520115 | 10952011 | Hypertension | |
109520115 | 10952011 | Hypotension | |
109520115 | 10952011 | Hypothermia | |
109520115 | 10952011 | Immunodeficiency | |
109520115 | 10952011 | Influenza | |
109520115 | 10952011 | Laryngeal oedema | |
109520115 | 10952011 | Memory impairment | |
109520115 | 10952011 | Mouth injury | |
109520115 | 10952011 | Movement disorder | |
109520115 | 10952011 | Muscle tightness | |
109520115 | 10952011 | Muscular weakness | |
109520115 | 10952011 | Myalgia | |
109520115 | 10952011 | Myocardial infarction | |
109520115 | 10952011 | Neck pain | |
109520115 | 10952011 | Nephrocalcinosis | |
109520115 | 10952011 | Nephrolithiasis | |
109520115 | 10952011 | Oesophageal candidiasis | |
109520115 | 10952011 | Pain | |
109520115 | 10952011 | Pyelonephritis | |
109520115 | 10952011 | Pyrexia | |
109520115 | 10952011 | Skin papilloma | |
109520115 | 10952011 | Somnolence | |
109520115 | 10952011 | Unevaluable event | |
109520115 | 10952011 | Urinary tract infection | |
109520115 | 10952011 | Weight decreased |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
109520115 | 10952011 | 1 | 20120103 | 0 | ||
109520115 | 10952011 | 2 | 201207 | 0 | ||
109520115 | 10952011 | 3 | 20130201 | 0 | ||
109520115 | 10952011 | 4 | 201405 | 0 | ||
109520115 | 10952011 | 5 | 201410 | 0 |